Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.

por Scambia, G., Benedetti, P., Ferrandina, G., Battaglia, F., Baiocchi, G., Mancuso, S.
Publicado 1991

Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis.

por Ferrandina, G., Scambia, G., Bardelli, F., Benedetti Panici, P., Mancuso, S., Messori, A.
Publicado 1997

Cathepsin D and epidermal growth factor in human breast cyst fluid.

por Scambia, G., Benedetti Panici, P., Ferrandina, G., Battaglia, F., Rossi, S., Bellantone, R., Crucitti, F., Mancuso, S.
Publicado 1991

Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome.

por Ferrandina, G., Scambia, G., Fagotti, A., D'Agostino, G., Benedetti Panici, P., Carbone, A., Mancuso, S.
Publicado 1998

Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.

por Marone, M., Scambia, G., Ferrandina, G., Giannitelli, C., Benedetti-Panici, P., Iacovella, S., Leone, A., Mancuso, S.
Publicado 1996

Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.

por Scambia, G., Benedetti-Panici, P., Ferrandina, G., Distefano, M., Salerno, G., Romanini, M. E., Fagotti, A., Mancuso, S.
Publicado 1995

Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer

por D'Agostino, G, Ferrandina, G, Ludovisi, M, Testa, A, Lorusso, D, Gbaguidi, N, Breda, E, Mancuso, S, Scambia, G
Publicado 2003

hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer

por Ercoli, A, Ferrandina, G, Raspaglio, G, Marone, M, Maggiano, N, Mastro, P Del, Panici, P Benedetti, Mancuso, S, Scambia, G
Publicado 1999

Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients

por Ferrandina, G, Petrillo, M, Carbone, A, Zannoni, G, Martinelli, E, Prisco, M, Pignata, S, Breda, E, Savarese, A, Scambia, G
Publicado 2008

Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors.

por Scambia, G., Catozzi, L., Benedetti Panici, P., Ferrandina, G., Almadori, G., Paludetti, G., Cadoni, G., Distefano, M., Piffanelli, A., Mancuso, S.
Publicado 1994

Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters

por Ferrandina, G, Legge, F, Martinelli, E, Ranelletti, F O, Zannoni, G F, Lauriola, L, Gessi, M, Gallotta, V, Scambia, G
Publicado 2005

Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines

por Ferlini, C, Scambia, G, Marone, M, Distefano, M, Gaggini, C, Ferrandina, G, Fattorossi, A, Isola, G, Panici, P Benedetti, Mancuso, S
Publicado 1999

Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial

por Ferrandina, G, Sallustio, G, Fagotti, A, Vizzielli, G, Paglia, A, Cucci, E, Margariti, A, Aquilani, L, Garganese, G, Scambia, G
Publicado 2009

Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma.

por Maurizi, M., Almadori, G., Ferrandina, G., Distefano, M., Romanini, M. E., Cadoni, G., Benedetti-Panici, P., Paludetti, G., Scambia, G., Mancuso, S.
Publicado 1996

Is the sarcomatous component (homologous vs heterologous) the prognostic “driving force” in early-stage uterine carcinosarcomas? A retrospective multicenter study

por Rosati, A., Vargiu, V., Certelli, C., Arcieri, M., Vizza, E., Legge, F., Cosentino, F., Ferrandina, G., Fanfani, F., Scambia, G., Corrado, G.
Publicado 2023

Prognostic significance of methyl-p-hydroxy-phenyllactate-esterase activity in laryngeal squamous cell carcinoma.

por Maurizi, M., Ferrandina, G., Almadori, G., Scambia, G., Cadoni, G., D'Agostino, G., Serra, F. G., Piantelli, M., Mancuso, S., Ranelletti, F. O.
Publicado 1998

Prognostic significance of ras/p21 alterations in human ovarian cancer.

por Scambia, G., Masciullo, V., Benedetti Panici, P., Marone, M., Ferrandina, G., Todaro, N., Bellacosa, A., Jain, S. K., Neri, G., Piffanelli, A., Mancuso, S.
Publicado 1997

Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells.

por Scambia, G., Ranelletti, F. O., Panici, P. B., Piantelli, M., Bonanno, G., De Vincenzo, R., Ferrandina, G., Rumi, C., Larocca, L. M., Mancuso, S.
Publicado 1990

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer

por Ferrandina, G, Fagotti, A, Salerno, M G, Natali, P G, Mottolese, M, Maneschi, F, Pasqua, A De, Benedetti-Panici, P, Mancuso, S, Scambia, G
Publicado 1999

Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications

por Ferrandina, G, Lauriola, L, Zannoni, G F, Distefano, M G, Legge, F, Salutari, V, Gessi, M, Maggiano, N, Scambia, G, Ranelletti, F O
Publicado 2002